[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100321243":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":33,"responsibleParty":53,"collaborators":18,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":18,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":65,"maxAge":18,"enrollmentInfo":66,"targetDuration":18,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":36,"whyStopped":18,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"University Medical Centre Ljubljana","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"patients with erythema migrans","ACTIVE_COMPARATOR","Patients will be treated with antibiotics for Lyme disease.",[13],"Drug: Antibiotics (preferentially oral doxycycline 100 mg bid)",{"label":15,"type":16,"description":17,"interventionNames":18},"controls","NO_INTERVENTION","Control subjects will not be given antibiotics.",null,[20],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":18},"DRUG","Antibiotics (preferentially oral doxycycline 100 mg bid)",[9],[25,30],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Daša Stupica","CONTACT","+38615222110","dasa.stupica@kclj.si",{"name":31,"role":27,"phone":28,"phoneExt":18,"email":32},"Maša Velušček","masa.veluscek@kclj.si",[34],{"facility":35,"status":36,"city":37,"state":18,"zip":18,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"University Medical center Ljubljana","RECRUITING","Ljubljana","Slovenia","SI",{"type":41,"coordinates":42},"Point",[43,44],14.50513,46.05108,{"lat":44,"lon":43},[47,50],{"name":48,"role":27,"phone":49,"phoneExt":18,"email":29},"Daša Stupica, MD, PhD","+386 31 689 324",{"name":51,"role":27,"phone":52,"phoneExt":18,"email":32},"Maša Velušček, MD","+386 1 522 21 10",{"type":54,"investigatorFullName":26,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","MD, PhD","100321243","patients-pretreatment-expectations-about-post-lyme-symptoms-100321243",false,"NCT03462329","Patient's Pretreatment Expectations About Post-Lyme Symptoms","Impact of Patient's Pretreatment Expectations on Treatment Outcome of Early Lyme Borreliosis","Inclusion Criteria:\n\n* erythema migrans\n\nExclusion Criteria:\n\n* pregnancy or lactation\n* immunocompromised\n* taking antibiotic with antiborrelial activity within 10 days",true,"ALL","18 Years",{"count":67,"type":68},200,"ESTIMATED","INTERVENTIONAL",[71],"NA","The investigators will focus on pretreatment expectations of patients with early Lyme disease manifested as erythema migrans with the aim of assessing the association between pretreatment expectations quantified with a questionnaire and treatment outcome quantified with the presence of post-Lyme symptoms. Furthermore, the investigators will compare the prevalence of nonspecific symptoms among patients and among age-matched controls without a history of Lyme borreliosis.",[74],"Erythema Migrans",[76,77],"Post-Lyme symptoms","Pretreatment expectations","2026-04-27",{"date":80,"type":81},"2026-04-29","ACTUAL",{"date":83,"type":81},"2018-06-01",{"date":85,"type":68},"2028-12-01",{"name":5,"class":6},1]